Skye Bioscience Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 13 Mar 24 | BuyUS$4,500,000 | 5AM Venture Management, LLC | Company | 450,000 | US$10.00 | |
| 31 Jan 24 | BuyUS$12,026,031 | 5AM Venture Management, LLC | Company | 5,206,074 | US$2.31 | |
| 29 Aug 23 | BuyUS$16,475 | Punit Dhillon | Individual | 3,524 | US$4.68 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 34,021 | 0.121% |
| Private Companies | 870,715 | 3.1% |
| Institutions | 1,417,364 | 5.05% |
| Hedge Funds | 3,303,036 | 11.8% |
| General Public | 10,255,564 | 36.5% |
| VC/PE Firms | 12,187,207 | 43.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 622.2%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 10,179,505 | US$79.1m | 125% | 19.81% | |||
| 2,007,702 | US$15.6m | 0% | 6.31% | |||
| 1,801,518 | US$14.0m | 0% | 8.48% | |||
| 1,501,518 | US$11.7m | 0% | 2.46% | |||
| 694,739 | US$5.4m | 0% | no data | |||
| 694,739 | US$5.4m | 0% | 1.96% | |||
| 677,633 | US$5.3m | 0% | no data | |||
| 193,082 | US$1.5m | 10.6% | no data | |||
| 28,304 | US$219.9k | 73.7% | no data | |||
| 26,000 | US$202.0k | 0% | 0.05% | |||
| 2,667 | US$20.7k | 99.9% | no data | |||
| 2,667 | US$20.7k | 0% | no data | |||
| 1,600 | US$12.4k | 0% | no data | |||
| 383 | US$3.0k | 0% | no data | |||
| 263 | US$2.1k | 0% | no data | |||
| 23 | US$174.5 | 0% | no data |